Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Harvard Business School
Farmers Insurance
Colorcon
Covington
Cantor Fitzgerald
Fuji
AstraZeneca
Cipla

Generated: June 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075367

« Back to Dashboard

NDA 075367 describes JUNIOR STRENGTH IBUPROFEN, which is a drug marketed by L Perrigo Co and is included in one NDA. Additional details are available on the JUNIOR STRENGTH IBUPROFEN profile page.

The generic ingredient in JUNIOR STRENGTH IBUPROFEN is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and sixty-six suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
Summary for 075367
Tradename:JUNIOR STRENGTH IBUPROFEN
Applicant:L Perrigo Co
Ingredient:ibuprofen
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength100MG
Approval Date:Apr 22, 1999TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Harvard Business School
Medtronic
Dow
McKesson
Julphar
Daiichi Sankyo
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.